In vivo laser Doppler flowmetry
Anesthesia was initiated with isoflurane (induction: 5%, maintenance: 2%) and maintained by intraperitoneal injections of 50 mg/kg of alpha-chloralose (Santa Cruz Biotechnology, USA) and 750 mg/kg of urethane (Sigma-Aldrich, USA). Mean blood pressure and blood gases were monitored via femoral artery catheterization. Ventilation was maintained artificially with a nitrogen/oxygen/CO2 mixture through a tracheal intubation. Body temperature was maintained at 37 ºC. Cerebral blood flow (CBF) was monitored by a laser Doppler probe (AD Instruments, USA) placed in a 2x2 mm cranial window drilled above the somatosensory cortex. Artificial cerebrospinal fluid (aCSF, NaCl 125 mM, KCl 3 mM, NaHCO3 26 mM, NaH2PO4H2O 1.25 mM, CaCl2 2 mM, MgCl26H2O 1mM, glucose 4 mM, ascorbic acid 0.4 mM, bubbled with 95% O2, 5% CO2 for 10 minutes) was superfused (0.5 mL/min, 35 ºC) after the removal of the pia mater. Analysis of CBF responses began 30 minutes after the end of the surgery to allow blood gases to stabilize. Animals with a mean arterial blood pressure under 60 mmHg and/or blood gases outside normal range were eliminated from the study. This comprised 5 animals for the CBF experiments with wild-type CD4 + CD25 + cells, 1 animal for the CBF experiment with the CD4 + CD25 + Il10 -/-cells and 6 animals for the CBF experiment with IL-10. The laser Doppler probe was placed stereotaxically above the whisker barrel area at the site of superfusion. CBF responses to neuronal activity were examined by whisker stimulation (three 1-minute stimulations at 6 Hz every 3 minutes on the contralateral side to CBF measurement). Endothelium-dependent CBF responses were measured after the superfusion of acetylcholine 10 M (Sigma-Aldrich, USA), superfused for 5 minutes followed by a 15 minutes aCSF superfusion to restore basal stimulation level. CBF values were acquired with the LabChart6 Pro software (v6.1.3, AD Instruments, USA). The percentage increase in CBF was measured using the CBF values before the stimulations and the maximum response.
Blood pressure
Systolic blood pressure was monitored by non-invasive tail-cuff plethysmography (Kent Scientific Corp., USA). The measures were taken 24 hours before analysis of cerebral blood flow. Mice were warmed on a heating pad preheated at 37 °C for 10 minutes before and during blood pressure recordings. Animals were habituated to the procedure the three days prior to blood pressure assessment. On the experimental day, following stabilization, ten blood pressure measurements per mouse were done and averaged for analysis. Data were not considered valid if the blood flow in the tail was below 15 µL.
Plasma cytokine/chemokine array and composite score calculation
Blood was collected via cardiac puncture in heparinized tubes. Samples were centrifuged at 2000 g for 20 minutes at 4°C to separate plasma. Cleared plasma samples were stored at −80°C and were only thawed for cytokine/chemokine analysis. A multiplex bead-based immunoassay from Eve Technologies Corporation (Calgary, AB, Canada) was used for the quantitative determination of 31 mouse plasma cytokines and chemokines (MD31 Discovery Assay, Mouse Cytokine/Chemokine Array 31-Plex). Plasma samples were diluted in half in PBS pH 7.4 and shipped on dry ice for analysis. The array measured the levels of Eotaxin (CCL11), G-CSF, GM-CSF, IFNγ, IL-1α, IL-1β, IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-9, IL-10, IL-12 (p40), IL-12 (p70), IL-13, IL-15, IL-17A, IP-10 (CXCL10), KC (CXCL1), LIF, LIX (CXCL5), MCP-1 (CCL2), M-CSF, MIG (CXCL9), MIP-1α, MIP-1β (CCL4), MIP-2 (CXCL2), RANTES (CCL5), TNFα and VEGF. Analyte concentrations were expressed in pg/mL and calculated through a standard curve from fluorescence intensity values. The following were not included in the final analysis due to low or no detection in several samples: IL-3, IL-7, IFNγ, IL-1β, GM-CSF, M-CSF, VEGF and MIP-1α. Given the large number of cytokines/chemokines analyzed a composite inflammatory Z score was computed to obtain a global measure reflecting inflammation and providing a more powered analysis. Prior to composite score calculation and in consultation with an immunologist (Dr. Jean-François Gauchat, Université de Montréal, Canada), cytokines and chemokines were grouped into four categories according to their main function/immune effect: I) Pro-inflammatory cytokines: IL-1α, IL-6, IL-17, TNF-α and LIF; II) Neutrophil chemoattractants: KC (CXCL1), LIX (CXCL5), MIP-2 (CXCL2) and stimulators of their development (G-CSF); III) Stimulators of Th1-driven responses: IL-12p40, IL12p70, MIP-1β (CCL4), RANTES (CCL5), MIG (CXCL9) and IP-10 (CXCL10); IV) Stimulators of Th2-driven responses: IL-4, IL-5, IL-9, IL-10, IL-13 and MCP-1 (CCL2). Eotaxin (CCL11) and IL-2 were not classified in any of the groups and are presented independently. The grouping does not intend to reflect the cellular source of each cytokine but rather their main action/effect as immune mediators. Within each group a cytokine/chemokine composite score was calculated for each mouse by converting each independent marker to a standardized Z score, such that the group mean was zero and the standard deviation was 1. Z scores were obtained with the formula z = (x -μ) / σ, where x was the individual value of the marker to be standardized, μ the mean of the dataset for that marker and σ the standard deviation. To generate the composite, Z scores within a group were added. PFA-fixed brain sections (40 μm thick) were incubated in 0.3% hydrogen peroxide (SigmaAldrich, USA) for 20 minutes followed by 3 washes in PBS and 1 wash in PBS-T (PBS + 0.2% Triton X-100). Blocking was done with 10% normal goat serum in PBS-T during 1 hour at room temperature. Microglia/monocytes were labeled with Iba-1 (1:2000, Wako Inc, Richmond, USA) in PBS-T with 10% goat serum, overnight at 4 ºC. The following day, sections were washed in PBS-T and incubated in biotinylated goat anti-rabbit antibody (ABC Kit, Vector) at 1:500 in PBS-T with 5% goat serum for 1 h. Signal amplification was done following manufacturer's instructions. Immunoreactions were developed with 0.06% 3,3'-diaminobenzidine and 1% hydrogen peroxide (Sigma-Aldrich, USA) in PBS. Following mounting, sections were dehydrated and defatted in increasing ethanol concentrations and xylenes, then coverslipped. Bright field images were taken with a Leitz Diaplan microscope equipped with an Olympus DP21 camera (Wild Leitz GmbH, Germany). Images were taken from layer V-VI of the somatosensory cortex (8 pictures per brain section) and from the hippocampal regions CA1, CA3 and DG (2 pictures per region per brain section). Micrographs were imported into the ImageJ software for calculation of microglial cell number. Each 8-bit image was thresholded with the intermodes method and converted to binary. The 'Analyze Particles' function was used to obtain the approximate number of microglia in the whole micrograph, using a size criteria of 150 pixels. Three different brain sections per animal were examined, and an average per region was calculated per section. Each was used for analysis.
Superoxide anion production
Brain cortical superoxide anion production was measured by lucigenin-enhanced chemiluminescence using a scintillation counter (Wallac 1409, Perkin Elmer, Canada) in out-ofcoincidence mode with a single active photomultiplier tube as previously described (Sadekova et al, JAHA 2013) . Cortical tissue was incubated at 37°C for 15 minutes in an oxygenated Krebs-HEPES buffer in the presence of 100 µmol/L NADPH (Sigma-Aldrich, Canada). Following the addition of lucigenin (5 µmol/L, Sigma-Aldrich, Canada) counts were obtained at 1-minute intervals during 10 minutes and corrected for background (reaction done without brain tissue). Superoxide production was determined based on the area under the curve (AUC) of counts/time. A second cortical sample was first incubated with the selective NOX-2 inhibitor, gp91ds-tat (50 µmol/L, AnaSpec, USA), in Krebs-HEPES buffer during 45 minutes, followed by the addition of NADPH and lucigenin. Counts were obtained as described above. Given that lucigenin detects superoxide anions from various enzymatic oxidase systems, NOX-2-derived superoxide production was expressed as the percentage of inhibition by gp91ds-tat relative to the amount of superoxide produced without the inhibitor. Each value was normalized to tissue weight. Figure S1 . Figure S11.
